A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

rare disease communities Archive

It’s Time For An Official Social Media Policy

Posted by | 11:49am on Thursday, May 19, 2016 | No Comments
Time for a Social Media Policy

Social media has been nothing short of a challenge in the pharmaceutical space from both a presence and advertising standpoint.  Manufacturers know that it makes sense but it has been difficult to be active when the advertising guidelines put out by the FDA are confusing, unclear, and sometimes just plain inaccurate.  Making matters worse and the guidelines even more suspect was the fact that the FDA was one of the few government agencies that didn’t even have its own social media policy.

All that changed in the middle of November (of 2015) when the FDA released its own policy on using social media.  This policy focused only on using social media and not advertising.  But it’s well thought out and a great benchmark when crafting your own policy.  That being said, it’s about time you think about developing your own social media policy.

Here are 5 points to think about when determining your own policy:

  • How do you plan to use social media?  To build community and encourage engagement, for marketing purposes, customer service or all of the above?
  • What social media channels do you plan to have a presence on?  Where are your patients or people you are targeting spending time?  Are they active on Facebook, twitter, Instagram, etc.?
  • What are all your consumer, patient, member touchpoints and who in your company currently interacts with these people in some way?
  • Who can post on behalf of the company on its respective social media properties?  How will engagement and questions be managed?  Related to this is that it’s imperative to define a social media content strategy from the onset.
  • Will you encourage employees to participate in social media or “try” to stymie personal use (no easy task)?  Consider providing guidelines for those who decide to participate such as a disclaimer indicating that the views are personal, conduct oneself in a mature/professional manner at all times, not disclosing information only privately available, etc.

While you’re crafting a social media policy, I’d suggest thinking about your entire social media presence too.  Given the way social media channels work, you will most likely need to advertise in order to be able to reach your target.  Even though the latest FDA Social Guidance is very general at best and includes some inaccurate suggestions at worst, it still provides parameters that should be adhered to when advertising via social media in the pharmaceutical space in order to remain compliant.  To be honest, the first two bullets would be the same as above with respect to advertising via social media:

  • How do you plan to use social media?  To build community and encourage engagement, for marketing purposes, customer service or all of the above?
  • What social media channels do you plan to have a presence on?  Where are your patients or people you are targeting spending time?  Facebook, twitter, Instagram, etc.?
  • Will your advertising be branded, unbranded, or both?  With limited characters available, defining this is vital when developing ads.
  • We strongly recommend having a separate budget for boosting Facebook posts from the rest of the more “traditional” online advertising that is ad based.

A well thought out social media policy, advertising plan, and content strategy can be the difference between a successful program (define success any way you want) and one that sputters and doesn’t result in the KPI’s you are looking for.  Leveraging the power of social media & digital advertising for community building, customer service, as part of a CRM program, and/or for more general advertising can be incredibly powerful and efficient if executed as part of a well thought out plan.

CDH Survivors

The More Things Change (as a Caregiver)

As a caregiver of a child with a rare disease, disorder, or birth defect, our job is multi-faceted.  My role…

Tags: , , , , , ,

Sickle Cell Anemia peripheral blood smear

New Medical Technique Spells Cure for Insidious Rare Disease

In 1973, people with sickle cell disease (SCD) had an average lifespan of only 14 years. But the situation has…

Tags: , , , , , ,

Facebook Stickers

More Robust Facebook Behavioral Targeting

There’s a lot more going on these days on Facebook than the ability to dislike a status update.  Facebook recently…

Tags: , , , , , , , ,


A Year in the Life of a Caregiver of a Child with a Rare Disorder

Congenital diaphragmatic hernia (CDH) occurs between approximately 1 in every 5,000 to 1 in every 2,000 births.  There is a…

Tags: , , ,


Patient-Powered Collaboration: ALD Connect Launches a Doctor-Patient Webinar Series

As part of our ongoing focus on multi-stakeholder collaboration in the rare disease space, we are highlighting successful and unique…

Tags: , , ,

FacialMetricsPresenting the additiontoRecognyz to the judges_L2RAfrahShafquat-JeremyWilliams-MichaelRogove

How Technology Will Improve the Future for Rare Diseases

Our collaboration with Global Genes and Sharon Moalem, MD, PhD at H@cking Medicine at the Massachusetts Institute of Technology (MIT)…

Tags: , , ,

Why Transparency Matters More Than Ever

Relationships are important in rare—and so are reputations. Rare disease communities are often small and closely knit. Patients and caregivers…

Tags: , , , ,


5 Ways to Speed Diagnosis of Our Children

You have probably heard the statistics before. There are 7,000 rare diseases. More than 80% are genetic. Half of those…

Tags: , , , , ,

NJ RARE 2013 Jane Castello Julie Raskin Francois Nader Debbie Hart Mary Cobb

Rare Disease and the Power of Partnership

One of the issues raised by the Affordable Care Act is the importance of decisions made at the state level…

Tags: , ,


Hacking the Diagnosis of Rare Diseases

Ed Fennell is a problem solver. After spending 35 years running a private consulting business, he’s turned his attention to…

Tags: , , ,

Creating Hope for Undiagnosed Patients

Most rare disease patients spend a good portion of their lives coping with a condition that is either undiagnosed or…

Tags: , , ,


Six Things NOT to Say to a Caregiver

I am a somewhat happy mother of 2 beautiful children, whom I love most days. I am happily married, again…

Tags: , , ,

A Search Engine To Help Diagnose Rare Diseases

If you are trying to diagnose a rare disease, plugging symptoms into Google will probably not be very helpful. In…

Tags: , , , ,


Why Rare Disease Caregivers Inspire Me

If you want to know the heights of love, compassion, determination, and self-sacrifice that people can rise to, just sit…

Tags: , ,

An Unstoppable Rare Disease Mom

Lisa Moreno-Dickinson may not have made Forbes’ list of the world’s most powerful people this year. But that is not…

Tags: , , , ,


Life According to Sam Exemplifies the Power of Caregivers

When a rare disease project gets mainstream attention, it’s a big deal. Exposure to a wider audience can make a…

Tags: , , , , ,

Diagnosis Is A Cause Everyone Can Get Behind

One of the most moving moments (and there were many of them) at Global Genes’ recent patient advocacy summit was…

Tags: , , , , , ,


Get Ready for Healthcare Reform

During a recent phone call arranged by the National Organization for Rare Disorders (NORD) to help members prepare for healthcare…

Tags: , ,

Guidelines for Movement Marketing

Movement marketing is a great way to empower patients by rallying them around a cause and motivating them to take…

Tags: , , ,

New Mexico

Geolocating a Cure for a Rare Disease

U.S.  Senator Tom Udall of New Mexico has introduced a bill that could be a bellwether for rare disease communities….

Tags: , , ,

Reaching Rare Disease Communities

Every once in awhile you stumble on a phrase that perfectly captures one of your  principles – something you’ve been…

Tags: , , , , , ,


Strides and Stripes for Primary Immunodeficiency Disease

Recently, the 2013 Immune Disease Foundation (IDF) National Conference “Back to Baltimore” brought together a community of patients, families, advocates,…

Tags: , , , ,

The First FDA Rare Disease Patient Advocacy Day

We are pleased to feature a guest blog post from Catherine Sohn. She has more than 20 years of pharmaceutical…


Power Panel Discussed Future of Healthcare

“Passion isn’t enough to make a difference,” said Pat Furlong, president of the Parent Project Muscular Dystrophy (PPMD), regarding the…


Can Online Health Information be Trusted?

The safety of internet health data has been an ongoing concern, as well as the subject of a good deal…



Advertising Never Started a Movement

It may be kinda weird to hear a marketer talking about the limits of advertising, but here I am. When…


Two Key Health Seeker Groups Most Active Online

Together the newly diagnosed and the chronically ill account for only 40% of the health seekers but 90% of the health seeking traffic.

Tags: ,


The Patient Journey

The internet allows relevant and compelling messaging that intersects patients at the best time, moving them more efficiently toward therapy,…


The “Long Tail” of SEO for Chronic Disease Communities

Your website is like your “virtual sales force” bringing in prospects from the all over the internet. Our research around…


Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com